Condition (MeSH)
Sudden Infant Death
ClinicalTrials.gov lists 79 trials for Sudden Infant Death or a narrower condition beneath it. Shire has the most among industry and government lead sponsors, with 7.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
79 of the 79 trials are tagged with Sudden Infant Death itself; the rest are tagged with a narrower condition beneath it.
When did Sudden Infant Death trials start? (25)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 9
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 5 |
| 2024 | 3 |
| 2023 | 4 |
| 2022 | 6 |
| 2021 | 4 |
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 9 |
| 2017 | 4 |
Showing 10 of 25 earlier years.
No forecast is made for this condition: it averages 4.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 42 months across 51 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Sudden Infant Death trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 1/2 | 7 |
| Phase 2 | 1 |
| Phase 2/3 | 8 |
| Phase 3 | 5 |
| Phase 4 | 2 |
| Not applicable | 27 |
| Observational | 26 |
How many Sudden Infant Death trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 8 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 7 |
| Completed | 42 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Sudden Infant Death trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Shire | 7 |
| REGENXBIO Inc. | 6 |
| Denali Therapeutics Inc. | 4 |
| Green Cross Corporation | 2 |
| AO GENERIUM | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Sudden Infant Death? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Idursulfase | 5 |
| tividenofusp alfa | 3 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Idursulfase IT (1 mg) | 3 |
| Long Term Follow-Up | 1 |
| GNR-055 2.0 mg/kg | 1 |
| Hematopoetic Stem Cell Transplantation | 1 |
| data collection | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Sudden Infant Death trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pyrexia | 13 | 5 |
| Device failure | 10 | 3 |
| Poor Venous Access | 10 | 1 |
| Cerebrospinal fluid leakage | 9 | 2 |
| Device dislocation | 9 | 3 |
Showing 5 of 10 adverse events.
Which publications cover Sudden Infant Death? (92)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Identification of novel genetic, neurobiological and radio-anatomical biomarkers for risk stratification of sudden unexpected death in infancy and early childhood: the BIOMINRISK study protocol. | BMJ open | 2025 | Yes |
| Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia. | The Cochrane database of systematic reviews | 2022 | Yes |
| Positioning for acute respiratory distress in hospitalised infants and children. | The Cochrane database of systematic reviews | 2022 | Yes |
| Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment. | Pediatrics | 2022 | Yes |
| Factors associated with age of death in sudden unexpected infant death. | Acta paediatrica (Oslo, Norway : 1992) | 2021 | Yes |
Showing 5 of 92 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.